Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Zhike Syrup
- Development stage
- Unknown
- Lead developer
- Zhangzhou Pien Tze Huang Pharmaceutical
- Administration
- Oral
01
Overview
Xiao'er Zhike Syrup is a traditional Chinese medicine (TCM) oral formulation developed and marketed by Zhangzhou Pientzehuang Pharmaceutical. It is specifically indicated for the treatment of cough and related respiratory symptoms in pediatric patients. As a TCM product, its therapeutic effects are derived from a combination of herbal ingredients intended to clear heat, ventilate the lungs, and resolve phlegm. The formulation is designed for ease of administration in children and is currently available as a marketed product in China.
- Brand names
- Xiao'er Zhike Syrup
- Other names
- Xiao'er Zhike TangjiangPediatric Cough Relief Syrup
Beyond the preview
Go deeper on Xiao'er Zhike Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiao'er Zhike Syrup.